AMICUS THERAPEUTICS, INC. Deferred Tax Assets, Other
AMICUS THERAPEUTICS, INC. had Deferred Tax Assets, Other of $7.39 million as of 2025-12-31, per its 10-K filed 2026-02-20.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsOther · last filed 2026-02-20
- 2025-12-31: Deferred Tax Assets, Other $7.39M.
- 2024-12-31: Deferred Tax Assets, Other $5.27M.
- 2023-12-31: Deferred Tax Assets, Other $20.86M.
- 2022-12-31: Deferred Tax Assets, Other $20.11M.
| Period end | Deferred Tax Assets, Other | Deferred Tax Assets, Other as first filed |
|---|---|---|
| 2025-12-31 | $7.39M 10-K · filed 2026-02-20 | |
| 2024-12-31 | $5.27M 10-K · filed 2026-02-20 | |
| 2023-12-31 | $20.86M 10-K · filed 2025-02-19 | |
| 2022-12-31 | $20.11M 10-K · filed 2024-02-28 | |
| 2021-12-31 | $17.75M 10-K · filed 2023-03-01 | $15.88M 10-K · filed 2022-02-24 |
| 2020-12-31 | $10.86M 10-K · filed 2022-02-24 | |
| 2019-12-31 | $13.92M 10-K · filed 2021-03-01 | $15.99M 10-K · filed 2020-03-02 |
| 2018-12-31 | $10.85M 10-K · filed 2020-03-02 | |
| 2017-12-31 | $7.33M 10-K · filed 2019-02-28 | |
| 2016-12-31 | $3.36M 10-K · filed 2018-03-01 | |
| 2015-12-31 | $2.96M 10-K/A · filed 2017-03-03 | |
| 2014-12-31 | $2.35M 10-K · filed 2016-02-29 |